|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
DELAWARE
|
|
56-1546236
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
Large accelerated filer
|
|
ý
|
|
Accelerated Filer
|
|
¨
|
|
|
|
|
|||
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
|
Page
|
PART I.
|
||
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
PART II.
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
|
Item 1.
|
|
Financial Statements
|
|
January 31,
2017 |
|
October 31,
2016* |
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
827,709
|
|
|
$
|
976,620
|
|
Short-term investments
|
138,648
|
|
|
140,695
|
|
||
Total cash, cash equivalents and short-term investments
|
966,357
|
|
|
1,117,315
|
|
||
Accounts receivable, net
|
331,984
|
|
|
438,873
|
|
||
Income taxes receivable and prepaid taxes
|
54,596
|
|
|
56,091
|
|
||
Prepaid and other current assets
|
131,106
|
|
|
104,659
|
|
||
Total current assets
|
1,484,043
|
|
|
1,716,938
|
|
||
Property and equipment, net
|
256,811
|
|
|
257,035
|
|
||
Goodwill
|
2,652,257
|
|
|
2,518,245
|
|
||
Intangible assets, net
|
301,922
|
|
|
266,661
|
|
||
Long-term prepaid taxes
|
15,800
|
|
|
13,991
|
|
||
Long-term deferred income taxes
|
355,469
|
|
|
281,926
|
|
||
Other long-term assets
|
197,952
|
|
|
185,569
|
|
||
Total assets
|
$
|
5,264,254
|
|
|
$
|
5,240,365
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable and accrued liabilities
|
$
|
251,098
|
|
|
$
|
401,451
|
|
Accrued income taxes
|
9,583
|
|
|
22,693
|
|
||
Deferred revenue
|
1,018,834
|
|
|
1,085,802
|
|
||
Short-term debt
|
177,040
|
|
|
205,000
|
|
||
Total current liabilities
|
1,456,555
|
|
|
1,714,946
|
|
||
Long-term accrued income taxes
|
37,394
|
|
|
39,562
|
|
||
Long-term deferred revenue
|
74,955
|
|
|
79,856
|
|
||
Long-term debt
|
142,500
|
|
|
—
|
|
||
Other long-term liabilities
|
228,165
|
|
|
210,855
|
|
||
Total liabilities
|
1,939,569
|
|
|
2,045,219
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value: 400,000 shares authorized; 150,428 and 151,454 shares outstanding, respectively
|
1,505
|
|
|
1,515
|
|
||
Capital in excess of par value
|
1,640,036
|
|
|
1,644,675
|
|
||
Retained earnings
|
2,137,395
|
|
|
1,947,585
|
|
||
Treasury stock, at cost: 6,836 and 5,811 shares, respectively
|
(355,257
|
)
|
|
(294,052
|
)
|
||
Accumulated other comprehensive income (loss)
|
(98,994
|
)
|
|
(104,577
|
)
|
||
Total stockholders’ equity
|
3,324,685
|
|
|
3,195,146
|
|
||
Total liabilities and stockholders’ equity
|
$
|
5,264,254
|
|
|
$
|
5,240,365
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
Revenue:
|
|
|
|
||||
Time-based products
|
$
|
489,365
|
|
|
$
|
464,280
|
|
Upfront products
|
79,609
|
|
|
43,437
|
|
||
Maintenance and service
|
83,812
|
|
|
60,887
|
|
||
Total revenue
|
652,786
|
|
|
568,604
|
|
||
Cost of revenue:
|
|
|
|
||||
Products
|
96,971
|
|
|
76,393
|
|
||
Maintenance and service
|
37,303
|
|
|
22,525
|
|
||
Amortization of intangible assets
|
21,472
|
|
|
30,526
|
|
||
Total cost of revenue
|
155,746
|
|
|
129,444
|
|
||
Gross margin
|
497,040
|
|
|
439,160
|
|
||
Operating expenses:
|
|
|
|
||||
Research and development
|
212,648
|
|
|
196,705
|
|
||
Sales and marketing
|
126,511
|
|
|
122,620
|
|
||
General and administrative
|
40,866
|
|
|
39,697
|
|
||
Amortization of intangible assets
|
8,036
|
|
|
6,935
|
|
||
Restructuring charges
|
12,105
|
|
|
2,093
|
|
||
Total operating expenses
|
400,166
|
|
|
368,050
|
|
||
Operating income
|
96,874
|
|
|
71,110
|
|
||
Other income (expense), net
|
11,487
|
|
|
(6,768
|
)
|
||
Income before income taxes
|
108,361
|
|
|
64,342
|
|
||
Provision (benefit) for income taxes
|
21,773
|
|
|
4,307
|
|
||
Net income
|
$
|
86,588
|
|
|
$
|
60,035
|
|
Net income per share:
|
|
|
|
||||
Basic
|
$
|
0.57
|
|
|
$
|
0.39
|
|
Diluted
|
$
|
0.56
|
|
|
$
|
0.39
|
|
Shares used in computing per share amounts:
|
|
|
|
||||
Basic
|
150,782
|
|
|
152,968
|
|
||
Diluted
|
154,433
|
|
|
155,283
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Net income
|
$
|
86,588
|
|
|
$
|
60,035
|
|
Other comprehensive income (loss):
|
|
|
|
||||
Change in foreign currency translation adjustment
|
(4,661
|
)
|
|
(14,455
|
)
|
||
Changes in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented
|
(63
|
)
|
|
(47
|
)
|
||
Cash flow hedges:
|
|
|
|
||||
Deferred gains (losses), net of tax of $(681) and $3,652, respectively
|
6,453
|
|
|
(12,634
|
)
|
||
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(850) and $(1,381), respectively
|
3,854
|
|
|
3,716
|
|
||
Other comprehensive income (loss), net of tax effects
|
5,583
|
|
|
(23,420
|
)
|
||
Comprehensive income
|
$
|
92,171
|
|
|
$
|
36,615
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
86,588
|
|
|
$
|
60,035
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
||||
Amortization and depreciation
|
49,464
|
|
|
56,436
|
|
||
Stock compensation
|
25,834
|
|
|
23,013
|
|
||
Allowance for doubtful accounts
|
229
|
|
|
250
|
|
||
(Gain) loss on sale of investments
|
(1
|
)
|
|
3
|
|
||
Write-down of long-term investments
|
1,300
|
|
|
—
|
|
||
Deferred income taxes
|
12,989
|
|
|
(3,955
|
)
|
||
Net changes in operating assets and liabilities, net of acquired assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
122,192
|
|
|
30,365
|
|
||
Prepaid and other current assets
|
(24,893
|
)
|
|
(27,825
|
)
|
||
Other long-term assets
|
(13,931
|
)
|
|
9,008
|
|
||
Accounts payable and accrued liabilities
|
(129,316
|
)
|
|
(145,229
|
)
|
||
Income taxes
|
(14,201
|
)
|
|
(5,174
|
)
|
||
Deferred revenue
|
(69,372
|
)
|
|
(32,097
|
)
|
||
Net cash provided by (used in) operating activities
|
46,882
|
|
|
(35,170
|
)
|
||
Cash flows from investing activities:
|
|
|
|
||||
Proceeds from sales and maturities of short-term investments
|
37,284
|
|
|
40,489
|
|
||
Purchases of short-term investments
|
(35,338
|
)
|
|
(34,933
|
)
|
||
Proceeds from sales of long-term investments
|
—
|
|
|
161
|
|
||
Purchases of property and equipment
|
(18,178
|
)
|
|
(15,337
|
)
|
||
Cash paid for acquisitions and intangible assets, net of cash acquired
|
(187,624
|
)
|
|
(18,941
|
)
|
||
Capitalization of software development costs
|
(1,033
|
)
|
|
(920
|
)
|
||
Other
|
2,100
|
|
|
—
|
|
||
Net cash used in investing activities
|
(202,789
|
)
|
|
(29,481
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from credit facility and term loan
|
150,000
|
|
|
30,000
|
|
||
Repayment of debt
|
(35,000
|
)
|
|
(7,500
|
)
|
||
Issuances of common stock
|
7,205
|
|
|
1,486
|
|
||
Payments for taxes related to net share settlement of equity awards
|
(6,887
|
)
|
|
(5,211
|
)
|
||
Purchase of equity forward contract
|
(20,000
|
)
|
|
(40,000
|
)
|
||
Purchases of treasury stock
|
(80,000
|
)
|
|
(160,000
|
)
|
||
Other
|
559
|
|
|
(1,030
|
)
|
||
Net cash provided by (used in) financing activities
|
15,877
|
|
|
(182,255
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(8,881
|
)
|
|
(6,296
|
)
|
||
Net change in cash and cash equivalents
|
(148,911
|
)
|
|
(253,202
|
)
|
||
Cash and cash equivalents, beginning of year
|
976,620
|
|
|
836,188
|
|
||
Cash and cash equivalents, end of period
|
$
|
827,709
|
|
|
$
|
582,986
|
|
(1)
|
Adjustments relate to changes in estimates for acquisitions that closed in the prior fiscal year for which the purchase price allocation was finalized during the reporting period.
|
|
Gross
Assets
|
|
Accumulated
Amortization
|
|
Net Assets
|
||||||
|
(in thousands)
|
||||||||||
Core/developed technology
|
$
|
622,954
|
|
|
$
|
479,000
|
|
|
$
|
143,954
|
|
Customer relationships
|
276,625
|
|
|
146,731
|
|
|
129,894
|
|
|||
Contract rights intangible
|
173,249
|
|
|
164,730
|
|
|
8,519
|
|
|||
Trademarks and trade names
|
25,129
|
|
|
14,763
|
|
|
10,366
|
|
|||
In-process research and development (IPR&D)(2)
|
4,600
|
|
|
—
|
|
|
4,600
|
|
|||
Capitalized software development costs
|
30,675
|
|
|
26,086
|
|
|
4,589
|
|
|||
Total
|
$
|
1,133,232
|
|
|
$
|
831,310
|
|
|
$
|
301,922
|
|
(2)
|
IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.
|
|
Gross
Assets
|
|
Accumulated
Amortization
|
|
Net Assets
|
||||||
|
(in thousands)
|
||||||||||
Core/developed technology
|
$
|
610,812
|
|
|
$
|
460,722
|
|
|
$
|
150,090
|
|
Customer relationships
|
235,997
|
|
|
139,932
|
|
|
96,065
|
|
|||
Contract rights intangible
|
171,248
|
|
|
162,183
|
|
|
9,065
|
|
|||
Trademarks and trade names
|
20,729
|
|
|
13,821
|
|
|
6,908
|
|
|||
Capitalized software development costs
|
29,642
|
|
|
25,109
|
|
|
4,533
|
|
|||
Total
|
$
|
1,068,428
|
|
|
$
|
801,767
|
|
|
$
|
266,661
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Core/developed technology
|
$
|
18,283
|
|
|
$
|
22,256
|
|
Customer relationships
|
6,892
|
|
|
6,193
|
|
||
Contract rights intangible
|
3,392
|
|
|
8,221
|
|
||
Trademarks and trade names
|
941
|
|
|
791
|
|
||
Capitalized software development costs(3)
|
977
|
|
|
915
|
|
||
Total
|
$
|
30,485
|
|
|
$
|
38,376
|
|
Fiscal Year
|
(in thousands)
|
||
Remainder of fiscal 2017
|
$
|
80,057
|
|
2018
|
81,585
|
|
|
2019
|
56,668
|
|
|
2020
|
39,470
|
|
|
2021
|
21,332
|
|
|
2022 and thereafter
|
18,210
|
|
|
IPR&D(4)
|
4,600
|
|
|
Total
|
$
|
301,922
|
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses Less Than 12 Months |
|
Gross
Unrealized Losses 12 Months or Longer |
|
Estimated
Fair Value(1) |
||||||||||
|
(in thousands)
|
||||||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
||||||||||
Money market funds
|
$
|
188,002
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
188,002
|
|
Commercial paper
|
2,849
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,849
|
|
|||||
Total:
|
$
|
190,851
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
190,851
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. government agency securities
|
$
|
12,305
|
|
|
$
|
—
|
|
|
$
|
(25
|
)
|
|
$
|
—
|
|
|
$
|
12,280
|
|
Certificates of deposit
|
20,963
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20,963
|
|
|||||
Commercial paper
|
24,831
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
24,832
|
|
|||||
Corporate debt securities
|
53,806
|
|
|
29
|
|
|
(36
|
)
|
|
—
|
|
|
53,799
|
|
|||||
Asset-backed securities
|
18,978
|
|
|
7
|
|
|
(18
|
)
|
|
—
|
|
|
18,967
|
|
|||||
Non-U.S. government agency securities
|
3,401
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
3,400
|
|
|||||
Other
|
4,407
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,407
|
|
|||||
Total:
|
$
|
138,691
|
|
|
$
|
37
|
|
|
$
|
(80
|
)
|
|
$
|
—
|
|
|
$
|
138,648
|
|
(1)
|
See
Note 6. Fair Value Measures
for further discussion on fair values of cash equivalents and short-term investments.
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses Less Than 12 Continuous Months |
|
Gross
Unrealized Losses 12 Continuous Months or Longer |
|
Estimated
Fair Value(1) |
||||||||||
|
(in thousands)
|
||||||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
||||||||||
Money market funds
|
$
|
499,274
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
499,274
|
|
Commercial paper
|
1,498
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,498
|
|
|||||
Certificates of deposit
|
4,200
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,200
|
|
|||||
Total:
|
$
|
504,972
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
504,972
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. government agency securities
|
$
|
13,607
|
|
|
$
|
4
|
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
|
$
|
13,603
|
|
Certificates of deposit
|
12,849
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,849
|
|
|||||
Commercial paper
|
25,430
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
25,431
|
|
|||||
Corporate debt securities
|
58,753
|
|
|
43
|
|
|
(18
|
)
|
|
—
|
|
|
58,778
|
|
|||||
Asset-backed securities
|
22,146
|
|
|
12
|
|
|
(12
|
)
|
|
—
|
|
|
22,146
|
|
|||||
Non-U.S. government agency securities
|
3,403
|
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
3,400
|
|
|||||
Other
|
4,488
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,488
|
|
|||||
Total:
|
$
|
140,676
|
|
|
$
|
60
|
|
|
$
|
(41
|
)
|
|
$
|
—
|
|
|
$
|
140,695
|
|
(1)
|
See
Note 6. Fair Value Measures
for further discussion on fair values of cash equivalents and short-term investments.
|
|
Amortized Cost
|
|
Fair Value
|
||||
|
(in thousands)
|
||||||
Due in 1 year or less
|
$
|
95,126
|
|
|
$
|
95,115
|
|
Due in 2-5 years
|
43,372
|
|
|
43,340
|
|
||
Due in 6-10 years
|
193
|
|
|
193
|
|
||
Total
|
$
|
138,691
|
|
|
$
|
138,648
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Gain (loss) recorded in other income (expense), net
|
$
|
59
|
|
|
$
|
(3,763
|
)
|
|
As of January 31, 2017
|
|
As of October 31, 2016
|
||||
|
(in thousands)
|
||||||
Total gross notional amount
|
$
|
702,768
|
|
|
$
|
758,246
|
|
Net fair value
|
$
|
418
|
|
|
$
|
(15,358
|
)
|
|
Fair values of
derivative instruments
designated as hedging
instruments
|
|
Fair values of
derivative instruments
not designated as
hedging instruments
|
||||
|
(in thousands)
|
||||||
As of January 31, 2017
|
|
|
|
||||
Other current assets
|
$
|
9,329
|
|
|
$
|
1,543
|
|
Accrued liabilities
|
$
|
10,389
|
|
|
$
|
66
|
|
As of October 31, 2016
|
|
|
|
||||
Other current assets
|
$
|
4,625
|
|
|
$
|
27
|
|
Accrued liabilities
|
$
|
19,910
|
|
|
$
|
101
|
|
|
Location of gain (loss)
recognized in OCI on
derivatives
|
|
Amount of gain (loss)
recognized in OCI on
derivatives
(effective portion)
|
|
Location of
gain (loss)
reclassified from OCI
|
|
Amount of
gain (loss)
reclassified from
OCI
(effective portion)
|
||||
|
(in thousands)
|
||||||||||
Three months ended
January 31, 2017 |
|
|
|
|
|
|
|
||||
Foreign exchange contracts
|
Revenue
|
|
$
|
8,604
|
|
|
Revenue
|
|
$
|
(1,753
|
)
|
Foreign exchange contracts
|
Operating expenses
|
|
(2,059
|
)
|
|
Operating expenses
|
|
(2,101
|
)
|
||
Total
|
|
|
$
|
6,545
|
|
|
|
|
$
|
(3,854
|
)
|
Three months ended
January 31, 2016 |
|
|
|
|
|
|
|
||||
Foreign exchange contracts
|
Revenue
|
|
$
|
(1,491
|
)
|
|
Revenue
|
|
$
|
212
|
|
Foreign exchange contracts
|
Operating expenses
|
|
(11,268
|
)
|
|
Operating expenses
|
|
(3,928
|
)
|
||
Total
|
|
|
$
|
(12,759
|
)
|
|
|
|
$
|
(3,716
|
)
|
Foreign exchange contracts
|
Amount of
gain (loss) recognized
in statement of operations
on derivatives
(ineffective
portion)(1)
|
|
Amount of gain (loss)
recognized in
statement of operations on
derivatives
(excluded from
effectiveness testing)(2)
|
||||
|
(in thousands)
|
||||||
For the three months ended January 31, 2017
|
$
|
168
|
|
|
$
|
1,118
|
|
For the three months ended January 31, 2016
|
$
|
254
|
|
|
$
|
1,402
|
|
(1)
|
The ineffective portion includes forecast inaccuracies.
|
(2)
|
The portion excluded from effectiveness testing includes the discount earned or premium paid for the contracts.
|
|
|
|
Fair Value Measurement Using
|
||||||||||||
Description
|
Total
|
|
Quoted Prices in
Active
Markets for Identical Assets
(Level 1)
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
(in thousands)
|
||||||||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
188,002
|
|
|
$
|
188,002
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Commercial paper
|
2,849
|
|
|
—
|
|
|
2,849
|
|
|
—
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
U.S. government agency securities
|
12,280
|
|
|
—
|
|
|
12,280
|
|
|
—
|
|
||||
Certificates of deposit
|
20,963
|
|
|
—
|
|
|
20,963
|
|
|
—
|
|
||||
Commercial paper
|
24,832
|
|
|
—
|
|
|
24,832
|
|
|
—
|
|
||||
Corporate debt securities
|
53,799
|
|
|
—
|
|
|
53,799
|
|
|
—
|
|
||||
Asset-backed securities
|
18,967
|
|
|
—
|
|
|
18,967
|
|
|
—
|
|
||||
Non-U.S. government agency securities
|
3,400
|
|
|
—
|
|
|
3,400
|
|
|
—
|
|
||||
Other
|
4,407
|
|
|
4,407
|
|
|
—
|
|
|
—
|
|
||||
Prepaid and other current assets:
|
|
|
|
|
|
|
|
||||||||
Foreign currency derivative contracts
|
10,872
|
|
|
—
|
|
|
10,872
|
|
|
—
|
|
||||
Other long-term assets:
|
|
|
|
|
|
|
|
||||||||
Deferred compensation plan assets
|
177,393
|
|
|
177,393
|
|
|
—
|
|
|
—
|
|
||||
Total assets
|
$
|
517,764
|
|
|
$
|
369,802
|
|
|
$
|
147,962
|
|
|
$
|
—
|
|
Liabilities
|
|
|
|
|
|
|
|
||||||||
Accounts payable and accrued liabilities:
|
|
|
|
|
|
|
|
||||||||
Foreign currency derivative contracts
|
$
|
10,454
|
|
|
$
|
—
|
|
|
$
|
10,454
|
|
|
$
|
—
|
|
Other long-term assets:
|
|
|
|
|
|
|
|
||||||||
Deferred compensation plan liabilities
|
177,393
|
|
|
177,393
|
|
|
—
|
|
|
—
|
|
||||
Total liabilities
|
$
|
187,847
|
|
|
$
|
177,393
|
|
|
$
|
10,454
|
|
|
$
|
—
|
|
|
|
|
Fair Value Measurement Using
|
||||||||||||
Description
|
Total
|
|
Quoted Prices in
Active
Markets for Identical Assets
(Level 1)
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
(in thousands)
|
||||||||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
499,274
|
|
|
$
|
499,274
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Commercial paper
|
1,498
|
|
|
—
|
|
|
1,498
|
|
|
—
|
|
||||
Certificates of deposit
|
4,200
|
|
|
—
|
|
|
4,200
|
|
|
—
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
U.S. government agency securities
|
13,603
|
|
|
—
|
|
|
13,603
|
|
|
—
|
|
||||
Certificates of deposit
|
12,849
|
|
|
—
|
|
|
12,849
|
|
|
—
|
|
||||
Commercial paper
|
25,431
|
|
|
—
|
|
|
25,431
|
|
|
—
|
|
||||
Corporate debt securities
|
58,778
|
|
|
—
|
|
|
58,778
|
|
|
—
|
|
||||
Asset-backed securities
|
22,146
|
|
|
—
|
|
|
22,146
|
|
|
—
|
|
||||
Non-U.S. government agency securities
|
3,400
|
|
|
—
|
|
|
3,400
|
|
|
—
|
|
||||
Other
|
4,488
|
|
|
4,488
|
|
|
—
|
|
|
—
|
|
||||
Prepaid and other current assets:
|
|
|
|
|
|
|
|
||||||||
Foreign currency derivative contracts
|
4,652
|
|
|
—
|
|
|
4,652
|
|
|
—
|
|
||||
Other long-term assets:
|
|
|
|
|
|
|
|
||||||||
Deferred compensation plan assets
|
163,185
|
|
|
163,185
|
|
|
—
|
|
|
—
|
|
||||
Total assets
|
$
|
813,504
|
|
|
$
|
666,947
|
|
|
$
|
146,557
|
|
|
$
|
—
|
|
Liabilities
|
|
|
|
|
|
|
|
||||||||
Accounts payable and accrued liabilities:
|
|
|
|
|
|
|
|
||||||||
Foreign currency derivative contracts
|
$
|
20,010
|
|
|
$
|
—
|
|
|
$
|
20,010
|
|
|
$
|
—
|
|
Other long-term liabilities:
|
|
|
|
|
|
|
|
||||||||
Deferred compensation plan liabilities
|
163,185
|
|
|
163,185
|
|
|
—
|
|
|
—
|
|
||||
Total liabilities
|
$
|
183,195
|
|
|
$
|
163,185
|
|
|
$
|
20,010
|
|
|
$
|
—
|
|
|
Balance as of January 31, 2017
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
(losses) during three months ended January 31, 2017
|
||||||
|
(in thousands)
|
||||||||||
Non-marketable equity securities
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1,300
|
)
|
(1)
|
Outstanding balance recorded in accounts payable and accrued liabilities as payroll and related benefits.
|
|
January 31,
2017 |
|
October 31,
2016 |
||||
|
(in thousands)
|
||||||
Payroll and related benefits
|
$
|
176,512
|
|
|
$
|
321,430
|
|
Other accrued liabilities
|
50,770
|
|
|
66,276
|
|
||
Accounts payable
|
23,816
|
|
|
13,745
|
|
||
Total
|
$
|
251,098
|
|
|
$
|
401,451
|
|
|
January 31,
2017 |
|
October 31,
2016 |
||||
|
(in thousands)
|
||||||
Deferred compensation liability
|
$
|
177,393
|
|
|
$
|
163,185
|
|
Other long-term liabilities
|
50,772
|
|
|
47,670
|
|
||
Total
|
$
|
228,165
|
|
|
$
|
210,855
|
|
Fiscal year
|
(in thousands)
|
||
2017
|
$
|
5,625
|
|
2018
|
10,313
|
|
|
2019
|
14,062
|
|
|
2020
|
17,813
|
|
|
2021
|
27,187
|
|
|
2022
|
75,000
|
|
|
Total
|
$
|
150,000
|
|
|
January 31,
2017 |
|
October 31,
2016 |
||||
|
(in thousands)
|
||||||
Cumulative currency translation adjustments
|
$
|
(89,361
|
)
|
|
$
|
(84,700
|
)
|
Unrealized gain (loss) on derivative instruments, net of taxes
|
(9,589
|
)
|
|
(19,896
|
)
|
||
Unrealized gain (loss) on available-for-sale securities, net of taxes
|
(44
|
)
|
|
19
|
|
||
Total accumulated other comprehensive income (loss)
|
$
|
(98,994
|
)
|
|
$
|
(104,577
|
)
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Reclassifications from accumulated other comprehensive income (loss) into unaudited condensed consolidated statement of operations:
|
|
|
|
||||
Gain (loss) on cash flow hedges, net of taxes
|
|
|
|
||||
Revenues
|
$
|
(1,753
|
)
|
|
$
|
212
|
|
Operating expenses
|
(2,101
|
)
|
|
(3,928
|
)
|
||
Gain (loss) on available-for-sale securities
|
|
|
|
||||
Other income (expense)
|
$
|
1
|
|
|
(3
|
)
|
|
Total reclassifications into net income
|
$
|
(3,853
|
)
|
|
$
|
(3,719
|
)
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Total shares repurchased (1)
|
1,393
|
|
|
3,849
|
|
||
Total cost of the repurchased shares(1)
|
$
|
80,000
|
|
|
$
|
180,000
|
|
Reissuance of treasury stock
|
368
|
|
|
200
|
|
(1)
|
Does not include the
258,710
shares and
$20.0 million
equity forward contract, respectively, from the December 2016 ASR settled in February 2017.
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Cost of products
|
$
|
2,999
|
|
|
$
|
2,596
|
|
Cost of maintenance and service
|
861
|
|
|
579
|
|
||
Research and development expense
|
12,884
|
|
|
11,585
|
|
||
Sales and marketing expense
|
5,129
|
|
|
4,701
|
|
||
General and administrative expense
|
3,961
|
|
|
3,552
|
|
||
Stock compensation expense before taxes
|
25,834
|
|
|
23,013
|
|
||
Income tax benefit
|
(7,071
|
)
|
|
(5,153
|
)
|
||
Stock compensation expense after taxes
|
$
|
18,763
|
|
|
$
|
17,860
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Intrinsic value of awards exercised
|
$
|
6,287
|
|
|
$
|
1,274
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands, except per share amounts)
|
||||||
Numerator:
|
|
|
|
||||
Net income
|
$
|
86,588
|
|
|
$
|
60,035
|
|
Denominator:
|
|
|
|
||||
Weighted-average common shares for basic net income per share
|
150,782
|
|
|
152,968
|
|
||
Dilutive effect of potential common shares from equity-based compensation
|
3,651
|
|
|
2,315
|
|
||
Weighted-average common shares for diluted net income per share
|
154,433
|
|
|
155,283
|
|
||
Net income per share:
|
|
|
|
||||
Basic
|
$
|
0.57
|
|
|
$
|
0.39
|
|
Diluted
|
$
|
0.56
|
|
|
$
|
0.39
|
|
Anti-dilutive employee stock-based awards excluded(1)
|
492
|
|
|
2,441
|
|
(1)
|
These employee stock-based awards were anti-dilutive for the respective periods and are excluded in calculating diluted net income per share. While such awards were anti-dilutive for the respective periods, they could be dilutive in the future.
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Revenue:
|
|
|
|
||||
United States
|
$
|
319,418
|
|
|
$
|
274,930
|
|
Europe
|
75,604
|
|
|
71,935
|
|
||
Japan
|
61,698
|
|
|
53,246
|
|
||
Asia-Pacific and Other
|
196,066
|
|
|
168,493
|
|
||
Consolidated
|
$
|
652,786
|
|
|
$
|
568,604
|
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Interest income
|
$
|
1,233
|
|
|
$
|
580
|
|
Interest expense
|
(1,308
|
)
|
|
(673
|
)
|
||
Gain (loss) on assets related to executive deferred compensation plan
|
7,781
|
|
|
(9,394
|
)
|
||
Foreign currency exchange gain (loss)
|
3,222
|
|
|
580
|
|
||
Other, net
|
559
|
|
|
2,139
|
|
||
Total
|
$
|
11,487
|
|
|
$
|
(6,768
|
)
|
|
Three Months Ended
January 31, |
||||||
|
2017
|
|
2016
|
||||
|
(in thousands)
|
||||||
Income before income taxes
|
$
|
108,361
|
|
|
$
|
64,342
|
|
Provision (benefit) for income taxes
|
$
|
21,773
|
|
|
$
|
4,307
|
|
Effective tax rate
|
20.1
|
%
|
|
6.7
|
%
|
Item 2.
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
•
|
Revenues were $652.8 million, an increase of $84.2 million, or 15%, primarily driven by the overall growth in our business due to increases of hardware sales, TSL license revenues and IP consulting projects and to a lesser extent from acquisitions.
|
•
|
Total costs and operating expenses were $555.9 million, an increase of $58.4 million, or 12%, primarily due to increases in headcount, including those from acquisitions, and higher product and consulting costs due to higher sales.
|
•
|
Higher operating income of $96.9 million, an increase of $25.8 million or 36%.
|
•
|
Our cash, cash equivalents and short-term investments were $966.4 million as of January 31, 2017, of which 16% was in the U.S.
|
•
|
Revenue recognition;
|
•
|
Valuation of business combinations;
|
•
|
Valuation of intangible assets; and
|
•
|
Income taxes.
|
•
|
Technology Subscription Licenses (TSLs).
TSLs are time-based licenses for a finite term, and generally provide the customer limited rights to receive, or to exchange certain quantities of licensed software for, unspecified future technology. The majority of our arrangements are TSLs due to the nature of the business and customer requirements. In addition to the licenses, the arrangements also include: post-contract customer support, which includes providing frequent updates and upgrades to maintain the utility of the software due to rapid changes in technology; other intertwined services such as multiple copies of the tools; assisting our customers in applying our technology in their development environment; and rights to remix licenses for other licenses.
|
•
|
Perpetual licenses.
Perpetual licenses continue as long as the customer renews maintenance plus an additional 20 years. Perpetual licenses do not provide the customer any rights to receive, or to exchange licensed software for, unspecified future technology. Customers purchase maintenance separately for the first year and may renew annually.
|
•
|
TSLs.
We typically recognize revenue from TSL fees ratably over the term of the license period, or as customer installments become due and payable, whichever is later. Revenue attributable to TSLs is reported as “time-based products revenue” in the unaudited condensed consolidated statements of operations.
|
•
|
Perpetual licenses.
We recognize revenue from perpetual licenses in full upon shipment of the software if payment terms require the customer to pay at least 75% of the license fee and 100% of the maintenance fee within one year from shipment and all other revenue recognition criteria are met. Revenue attributable to these perpetual licenses is reported as “upfront products revenue” in the unaudited condensed consolidated statements of operations. For perpetual licenses in which less than 75% of the license fee and 100% of the maintenance fee is payable within one year from shipment, we recognize revenue as customer installments become due and payable. Such revenue is reported as “time-based products revenue” in the unaudited condensed consolidated statements of operations.
|
•
|
In most instances, we recognize revenue on a TSL software license order over the license term and on a term or perpetual software license order in the quarter in which the license is delivered. The weighted-average term of the TSLs and term licenses is typically three years, but varies from quarter to quarter due to the nature and timing of the arrangements entered into during the quarter. For the three months ended
January 31, 2017
and
2016
, the weighted-average license term was 2.8 and 3.7 years, respectively.
|
•
|
Revenue on contracts requiring significant modification or development is accounted for using the percentage of completion method over the period of the development.
|
•
|
Revenue on hardware product orders is generally recognized in full at the time the product is shipped and when title is transferred.
|
•
|
Contingent revenue is recognized if and when the event that removes the contingency occurs.
|
•
|
Revenue on maintenance orders is recognized ratably over the maintenance period (normally one year).
|
•
|
Revenue on professional services orders is generally recognized as the services are performed.
|
•
|
Infrequently, we enter into certain license arrangements wherein licenses are provided for a finite term without any other services or rights, including rights to receive, or to exchange licensed software for, unspecified future technology. We recognize revenue from term licenses in full upon shipment of the software and when all other revenue recognition criteria are met.
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
652.8
|
|
|
$
|
568.6
|
|
|
$
|
84.2
|
|
|
15
|
%
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
489.4
|
|
|
$
|
464.3
|
|
|
$
|
25.1
|
|
|
5
|
%
|
Percentage of total revenue
|
75
|
%
|
|
82
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
79.6
|
|
|
$
|
43.4
|
|
|
$
|
36.2
|
|
|
83
|
%
|
Percentage of total revenue
|
12
|
%
|
|
8
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
|
|
|
|
|
|
|
|||||||
Maintenance revenue
|
$
|
19.4
|
|
|
$
|
18.0
|
|
|
$
|
1.4
|
|
|
8
|
%
|
Professional services and other revenue
|
64.4
|
|
|
42.9
|
|
|
21.5
|
|
|
50
|
%
|
|||
Total maintenance and service revenue
|
$
|
83.8
|
|
|
$
|
60.9
|
|
|
$
|
22.9
|
|
|
38
|
%
|
Percentage of total revenue
|
13
|
%
|
|
11
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
|
|
|
|
|
|
|
|||||||
Cost of products revenue
|
$
|
97.0
|
|
|
$
|
76.4
|
|
|
$
|
20.6
|
|
|
27
|
%
|
Cost of maintenance and service revenue
|
37.2
|
|
|
22.5
|
|
|
14.7
|
|
|
65
|
%
|
|||
Amortization of intangible assets
|
21.5
|
|
|
30.5
|
|
|
(9.0
|
)
|
|
(30
|
)%
|
|||
Total
|
$
|
155.7
|
|
|
$
|
129.4
|
|
|
$
|
26.3
|
|
|
20
|
%
|
Percentage of total revenue
|
24
|
%
|
|
23
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
212.6
|
|
|
$
|
196.7
|
|
|
$
|
15.9
|
|
|
8
|
%
|
Percentage of total revenue
|
33
|
%
|
|
35
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
126.5
|
|
|
$
|
122.6
|
|
|
$
|
3.9
|
|
|
3
|
%
|
Percentage of total revenue
|
19
|
%
|
|
22
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
$
|
40.9
|
|
|
$
|
39.7
|
|
|
$
|
1.2
|
|
|
3
|
%
|
Percentage of total revenue
|
6
|
%
|
|
7
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
|
|
|
|
|
|
|
|||||||
Included in cost of revenue
|
$
|
21.5
|
|
|
$
|
30.5
|
|
|
$
|
(9.0
|
)
|
|
(30
|
)%
|
Included in operating expenses
|
8.0
|
|
|
6.9
|
|
|
1.1
|
|
|
16
|
%
|
|||
Total
|
$
|
29.5
|
|
|
$
|
37.4
|
|
|
$
|
(7.9
|
)
|
|
(21
|
)%
|
Percentage of total revenue
|
5
|
%
|
|
7
|
%
|
|
|
|
|
|
January 31,
|
|
|
|
|
|||||||||
|
2017
|
|
2016
|
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Three months ended
|
|
|
|
|
|
|
|
|||||||
Interest income
|
$
|
1.2
|
|
|
$
|
0.6
|
|
|
$
|
0.6
|
|
|
100
|
%
|
Interest (expense)
|
(1.3
|
)
|
|
(0.7
|
)
|
|
(0.6
|
)
|
|
86
|
%
|
|||
Gain (loss) on assets related to executive deferred compensation plan
|
7.8
|
|
|
(9.4
|
)
|
|
17.2
|
|
|
(183
|
)%
|
|||
Foreign currency exchange gain (loss)
|
3.2
|
|
|
0.6
|
|
|
2.6
|
|
|
433
|
%
|
|||
Other, net
|
0.6
|
|
|
2.1
|
|
|
(1.5
|
)
|
|
(71
|
)%
|
|||
Total
|
$
|
11.5
|
|
|
$
|
(6.8
|
)
|
|
$
|
18.3
|
|
|
(269
|
)%
|
|
January 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Cash and cash equivalents
|
$
|
827.7
|
|
|
$
|
976.6
|
|
|
$
|
(148.9
|
)
|
|
(15
|
)%
|
Short-term investments
|
$
|
138.7
|
|
|
$
|
140.7
|
|
|
$
|
(2.0
|
)
|
|
(1
|
)%
|
Total
|
$
|
966.4
|
|
|
$
|
1,117.3
|
|
|
$
|
(150.9
|
)
|
|
(14
|
)%
|
|
January 31,
|
|
|
||||||||
|
2017
|
|
2016
|
|
$ Change
|
||||||
|
(dollars in millions)
|
||||||||||
Three months ended
|
|
|
|
|
|
||||||
Cash provided by (used in) operating activities
|
$
|
46.9
|
|
|
$
|
(35.2
|
)
|
|
$
|
82.1
|
|
Cash (used in) investing activities
|
(202.8
|
)
|
|
(29.5
|
)
|
|
(173.3
|
)
|
|||
Cash provided by (used in) by financing activities
|
15.9
|
|
|
(182.3
|
)
|
|
198.2
|
|
|
January 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Accounts Receivable, net
|
$
|
332.0
|
|
|
$
|
438.9
|
|
|
$
|
(106.9
|
)
|
|
(24
|
)%
|
|
January 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|||||||
|
(dollars in millions)
|
|||||||||||||
Current assets
|
$
|
1,484.0
|
|
|
$
|
1,716.9
|
|
|
$
|
(232.9
|
)
|
|
(14
|
)%
|
Current liabilities
|
1,456.6
|
|
|
1,714.9
|
|
|
(258.3
|
)
|
|
(15
|
)%
|
|||
Working capital
|
$
|
27.4
|
|
|
$
|
2.0
|
|
|
$
|
25.4
|
|
|
1,270
|
%
|
Item 3.
|
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
|
Controls and Procedures
|
(a)
|
Evaluation of Disclosure Controls and Procedures.
As of
January 31, 2017
, Synopsys carried out an evaluation under the supervision and with the participation of Synopsys’ management, including the Co-Chief Executive Officers and Chief Financial Officer, of the effectiveness of the design and operation of Synopsys’ disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives. Our Co-Chief Executive Officers and Chief Financial Officer have concluded that, as of
January 31, 2017
, Synopsys’ disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports Synopsys files and submits under the Exchange Act is recorded, processed, summarized and reported as and when required, and that such information is accumulated and communicated to Synopsys’ management, including the Co-Chief Executive Officers and Chief Financial Officer, to allow timely decisions regarding its required disclosure.
|
(b)
|
Changes in Internal Control over Financial Reporting.
There were no changes in Synopsys’ internal control over financial reporting during the three months ended
January 31, 2017
that have materially affected, or are reasonably likely to materially affect, Synopsys’ internal control over financial reporting.
|
Item 1.
|
|
Legal Proceedings
|
Item 1A.
|
|
Risk Factors
|
•
|
Potential negative impact on our earnings per share;
|
•
|
Failure of acquired products to achieve projected sales;
|
•
|
Problems in integrating the acquired products with our products;
|
•
|
Difficulties entering into new markets in which we are not experienced or where competitors may have stronger positions;
|
•
|
Potential downward pressure on operating margins due to lower operating margins of acquired businesses, increased headcount costs and other expenses associated with adding and supporting new products;
|
•
|
Difficulties in retaining and integrating key employees;
|
•
|
Substantial reductions of our cash resources and/or the incurrence of debt;
|
•
|
Failure to realize expected synergies or cost savings;
|
•
|
Difficulties in integrating or expanding sales, marketing and distribution functions and administrative systems, including information technology and human resources systems;
|
•
|
Dilution of our current stockholders through the issuance of common stock as part of the merger consideration;
|
•
|
Assumption of unknown liabilities, including tax and litigation, and the related expenses and diversion of resources;
|
•
|
Disruption of ongoing business operations, including diversion of management’s attention and uncertainty for employees and customers, particularly during the post-acquisition integration process;
|
•
|
Potential negative impact on our relationships with customers, distributors and business partners;
|
•
|
Exposure to new operational risks, regulations, and business customs to the extent acquired businesses are located in regions where we are not currently conducting business;
|
•
|
The need to implement controls, processes and policies appropriate for a public company at acquired companies that may have lacked such controls, processes and policies;
|
•
|
Negative impact on our net income resulting from acquisition-related costs; and
|
•
|
Requirements imposed by government regulators in connection with their review of an acquisition, including required divestitures or restrictions on the conduct of our business or the acquired business.
|
•
|
Changes in demand for our products due to fluctuations in demand for our customers’ products and due to constraints in our customers’ budgets for research and development and EDA products and services;
|
•
|
Product competition in the EDA industry, which can change rapidly due to industry or customer consolidation and technological innovation;
|
•
|
Our ability to innovate and introduce new products and services or effectively integrate products and technologies that we acquire;
|
•
|
Failures or delays in completing sales due to our lengthy sales cycle, which often includes a substantial customer evaluation and approval process because of the complexity of our products and services;
|
•
|
Our ability to implement effective cost control measures;
|
•
|
Our dependence on a relatively small number of large customers, and on such customers continuing to renew licenses and purchase additional products from us, for a large portion of our revenue;
|
•
|
Changes in the mix of our products sold, as increased sales of our products with lower gross margins, such as our hardware products, may reduce our overall margins;
|
•
|
Expenses related to our acquisition and integration of businesses and technology;
|
•
|
Changes to our effective tax rate;
|
•
|
Delays, increased costs or quality issues resulting from our reliance on third parties to manufacture our hardware products, which include a sole supplier for certain hardware components; and
|
•
|
General economic and political conditions that affect the semiconductor and electronics industries.
|
•
|
Cancellations or changes in levels of orders or the mix between upfront products revenue and time-based products revenue;
|
•
|
Delay of one or more orders for a particular period, particularly orders generating upfront products revenue;
|
•
|
Delay in the completion of professional services projects that require significant modification or customization and are accounted for using the percentage of completion method;
|
•
|
Delay in the completion and delivery of IP products in development that customers have paid for early access to;
|
•
|
Customer contract amendments or renewals that provide discounts or defer revenue to later periods;
|
•
|
The levels of our hardware revenues, which are recognized upfront and are primarily dependent upon our ability to provide the latest technology and meet customer requirements, and which may also impact our levels of excess and obsolete inventory expenses; and
|
•
|
Changes in our revenue recognition model.
|
•
|
Our ability to anticipate and lead critical development cycles and technological shifts, innovate rapidly and efficiently, improve our existing products, and successfully develop or acquire new products;
|
•
|
Our ability to offer products that provide both a high level of integration into a comprehensive platform and a high level of individual product performance;
|
•
|
Our ability to enhance the value of our offerings through more favorable terms such as expanded license usage, future purchase rights, price discounts and other unique rights, such as multiple tool copies, post-contract customer support, “re-mix” rights that allow customers to exchange the software they initially licensed for other Synopsys products, and the ability to purchase pools of technology
|
•
|
Our ability to compete on the basis of payment terms; and
|
•
|
Our ability to provide engineering and design consulting for our products.
|
•
|
Our ability to attract a new customer base, including in industries in which we have less experience;
|
•
|
Our successful development of new sales and marketing strategies to meet customer requirements;
|
•
|
Our ability to accurately predict, prepare for, and promptly respond to technological developments in new fields, including, in the case of our software quality, testing, and security tools and services, identifying new security vulnerabilities in software code and ensuring support for a growing number of programming languages;
|
•
|
Our ability to compete with new and existing competitors in these new industries, many of which may have more financial resources, industry experience, brand recognition, or established customer relationships than we currently do;
|
•
|
Our ability to skillfully balance our investment in adjacencies with investment in our existing products;
|
•
|
Our ability to attract and retain employees with expertise in new fields;
|
•
|
Our ability to sell and support consulting services at profitable margins; and
|
•
|
Our ability to manage our revenue model in connection with hybrid sales of licensed products and consulting services.
|
•
|
Assert claims of infringement of our intellectual property;
|
•
|
Defend our products from piracy;
|
•
|
Protect our trade secrets or know-how; or
|
•
|
Determine the enforceability, scope and validity of the propriety rights of others.
|
•
|
Ineffective legal protection of intellectual property rights;
|
•
|
International economic and political conditions in countries where we do business, such as uncertainty caused by the United Kingdom's referendum to withdraw from the European Union;
|
•
|
Difficulties in adapting to cultural differences in the conduct of business, which may include business practices that we are prohibited from engaging in by the Foreign Corrupt Practices Act or other anti-corruption laws;
|
•
|
Financial risks such as longer payment cycles and difficulty in collecting accounts receivable;
|
•
|
Inadequate local infrastructure that could result in business disruptions;
|
•
|
Government trade restrictions, including tariffs, export licenses, or other trade barriers, and changes to existing trade arrangements between various countries;
|
•
|
Additional taxes, interest, and potential penalties; and
|
•
|
Other factors beyond our control such as natural disasters, terrorism, civil unrest, war and infectious diseases.
|
•
|
Increased dependence on a sole supplier for certain hardware components, which may reduce our control over product quality and pricing and may lead to delays in production and delivery of our hardware products, should our supplier fail to deliver sufficient quantities of acceptable components in a timely fashion;
|
•
|
Increasingly variable revenue and decreasingly accurate revenue forecasts, due to fluctuations in hardware revenue, which is recognized upfront upon shipment, as opposed to sales of most software products for which revenue is recognized over time;
|
•
|
Overall reductions in margins, as the gross margin for our hardware products is typically lower than those of our software products;
|
•
|
Longer sales cycles, which create risks of insufficient, excess or obsolete inventory and variations in inventory valuation, which can adversely affect our operating results;
|
•
|
Decreases or delays in customer purchases in favor of next-generation releases, which may lead to excess or obsolete inventory or require us to discount our older hardware products; and
|
•
|
Longer warranty periods than those of our software products, which may require us to replace hardware components under warranty, thus increasing our costs.
|
Item 2.
|
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period (1)
|
|
Total number
of shares
purchased
|
|
Average
price paid
per share
|
|
Total number of
shares purchased
as part of
publicly
announced
programs
|
|
Maximum dollar
value of shares
that may yet be
purchased
under the
programs (1)
|
||||||
Month #1
|
|
|
|
|
|
|
|
|
||||||
October 30, 2016 through December 3, 2016(2)
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
435,479,280
|
|
Month #2
|
|
|
|
|
|
|
|
|
||||||
December 4, 2016 through December 31, 2016(2)
|
|
1,393,243
|
|
|
$
|
57.4200
|
|
|
1,393,243
|
|
|
$
|
335,479,280
|
|
Month #3
|
|
|
|
|
|
|
|
|
||||||
January 1, 2017 through January 28, 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
Total
|
|
1,393,243
|
|
|
|
|
1,393,243
|
|
|
$
|
335,479,280
|
|
||
|
|
|
|
|
|
|
|
|
(1)
|
As of
January 31, 2017
,
$335.5
million remained available for future repurchases under the program.
|
(2)
|
The number of shares purchased and average purchase price paid per share does not include the
258,710
shares and
$20.0 million
equity forward contract, respectively, from the December 2016 ASR settled in February 2017.
|
Item 6.
|
|
Exhibits
|
Exhibit
Number
|
|
|
|
Incorporated By Reference
|
|
Filed
Herewith
|
||||||
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
3.1
|
|
Amended and Restated Certificate of Incorporation
|
|
10-Q
|
|
000-19807
|
|
3.1
|
|
9/15/2003
|
|
|
3.2
|
|
Amended and Restated Bylaws
|
|
8-K
|
|
000-19807
|
|
3.2
|
|
5/23/2012
|
|
|
4.1
|
|
Specimen Common Stock Certificate
|
|
S-1
|
|
33-45138
|
|
4.3
|
|
2/24/92 (effective date)
|
|
|
10.5*
|
|
Form of Restricted Stock
Unit Grant Notice and
Award Agreement under
2006 Employee Equity
Incentive Plan
|
|
|
|
|
|
|
|
|
|
X
|
10.6*
|
|
Form of Notice of Grant of
Stock Options and Option
Agreement under 2006
Employee Equity Incentive
Plan
|
|
|
|
|
|
|
|
|
|
X
|
10.16*
|
|
Amended and Restated Employment Agreement, dated December 15, 2016, by and between Synopsys, Inc. and Dr. Aart de Geus
|
|
8-K
|
|
000-19807
|
|
10.16
|
|
12/21/2016
|
|
|
10.17*
|
|
Amended and Restated Employment Agreement, dated December 15, 2016, by and between Synopsys, Inc. and Dr. Chi-Foon Chan
|
|
8-K
|
|
000-19807
|
|
10.17
|
|
12/21/2016
|
|
|
10.18*
|
|
Executive Incentive Plan, as amended on December 15, 2016
|
|
8-K
|
|
000-19807
|
|
10.18
|
|
12/21/2016
|
|
|
10.19*
|
|
Amended and Restated Executive Change of Control Severance Benefit Plan, as amended on December 15, 2016
|
|
8-K
|
|
000-19807
|
|
10.19
|
|
12/21/2016
|
|
|
31.1
|
|
Certification of Co-Principal Executive Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
31.2
|
|
Certification of Co-Principal Executive Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
31.3
|
|
Certification of Principal Financial Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
Exhibit
Number
|
|
|
|
Incorporated By Reference
|
|
Filed
Herewith
|
||||||
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
32.1
|
|
Certification of Co-Principal Executive Officers and Principal Financial Officer furnished pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code
|
|
|
|
|
|
|
|
|
|
X
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
SYNOPSYS, INC.
|
|
|
|
|
Date: February 17, 2017
|
By:
|
/s/ T
RAC
P
HAM
|
|
|
Trac Pham
Chief Financial Officer
(Principal Financial Officer)
|
Exhibit
Number
|
|
|
|
Incorporated By Reference
|
|
Filed
Herewith
|
||||||
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
3.1
|
|
Amended and Restated Certificate of Incorporation
|
|
10-Q
|
|
000-19807
|
|
3.1
|
|
9/15/2003
|
|
|
3.2
|
|
Amended and Restated Bylaws
|
|
8-K
|
|
000-19807
|
|
3.2
|
|
5/23/2012
|
|
|
4.1
|
|
Specimen Common Stock Certificate
|
|
S-1
|
|
33-45138
|
|
4.3
|
|
2/24/92 (effective date)
|
|
|
10.5*
|
|
Form of Restricted Stock
Unit Grant Notice and
Award Agreement under
2006 Employee Equity
Incentive Plan
|
|
|
|
|
|
|
|
|
|
X
|
10.6*
|
|
Form of Notice of Grant of
Stock Options and Option
Agreement under 2006
Employee Equity Incentive
Plan
|
|
|
|
|
|
|
|
|
|
X
|
10.16*
|
|
Amended and Restated Employment Agreement, dated December 15, 2016, by and between Synopsys, Inc. and Dr. Aart de Geus
|
|
8-K
|
|
000-19807
|
|
10.16
|
|
12/21/2016
|
|
|
10.17*
|
|
Amended and Restated Employment Agreement, dated December 15, 2016, by and between Synopsys, Inc. and Dr. Chi-Foon Chan
|
|
8-K
|
|
000-19807
|
|
10.17
|
|
12/21/2016
|
|
|
10.18*
|
|
Executive Incentive Plan, as amended on December 15, 2016
|
|
8-K
|
|
000-19807
|
|
10.18
|
|
12/21/2016
|
|
|
10.19*
|
|
Amended and Restated Executive Change of Control Severance Benefit Plan, as amended on December 15, 2016
|
|
8-K
|
|
000-19807
|
|
10.19
|
|
12/21/2016
|
|
|
31.1
|
|
Certification of Co-Principal Executive Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
31.2
|
|
Certification of Co-Principal Executive Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
31.3
|
|
Certification of Principal Financial Officer furnished pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
|
|
|
|
|
|
|
|
|
|
X
|
32.1
|
|
Certification of Co-Principal Executive Officers and Principal Financial Officer furnished pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code
|
|
|
|
|
|
|
|
|
|
X
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
Payment for Common Stock:
|
Participant’s future services
|
PARTICIPANT:
|
Your address as on file with the Company at the time notice is given
|
I.
|
you agree that any Employer’s Liability that may arise in connection with or pursuant to the exercise or vesting of the Award, as applicable (and the acquisition of shares of the Company’s common stock) or other taxable events in connection with the Award will be transferred to you; and
|
II.
|
you authorise the Company and/or your employer to recover an amount sufficient to cover this liability by any method set forth in the relevant Award Agreement and/or the Joint Election.
|
1.
|
Parties
|
(A)
|
You, the individual who has obtained access to this Election (the “Participant”), who is employed by one of the employing companies listed in the attached schedule (the “Employer”) and who is eligible to receive stock options (“Options”) and/or restricted stock units (“RSUs”) (each an “Award” and together, the “Awards”) pursuant to the terms and conditions of the Synopsys, Inc. 2006 Employee Equity Incentive Plan (the “Plan”), and
|
(B)
|
Synopsys, Inc. of 690 East Middlefield Road, Mountain View, California 94043, United States (the “Company”), which may grant Awards under the Plan and is entering this Election on behalf of the Employer.
|
2.
|
Purpose of Election
|
2.1
|
This Election relates to the Employer's secondary Class 1 National Insurance Contributions (the “Employer's Liability”) which may arise on the occurrence of a “Taxable Event” which gives rise to relevant employment income within section 4(4)(a) and/or paragraph 3B(1A) of Schedule 1 of the Social Security Contributions and Benefits Act 1992 (“SSCBA”), including but not limited to:
|
a.
|
the acquisition of securities pursuant to the Awards (pursuant to section 477(3)(a) ITEPA); and/or
|
b.
|
the assignment or release of the Awards in return for consideration (pursuant to section 477(3)(b) ITEPA); and/or
|
c.
|
the receipt of any other benefit in connection with the Awards other than a benefit within (i) or (ii) above (pursuant to section 477(3)(c) ITEPA); and/or
|
d.
|
post-acquisition events relating to the Awards or the securities acquired pursuant to the Awards (within section 426 ITEPA); and/or
|
e.
|
post-acquisition events relating to the Awards or the securities acquired pursuant to the Awards (within section 438 ITEPA).
|
2.2
|
This Election is made in accordance with paragraph 3B(1) of Schedule 1 to SSCBA.
|
2.3
|
This Election applies to all Awards granted to the Participant under the Plan on or after May 22, 2009 up to the termination date of the Plan.
|
2.4
|
This Election does not apply in relation to any liability, or any part of any liability, arising as a result of regulations being given retrospective effect by virtue of section 4B(2) of either the SSCBA, or the Social Security Contributions and Benefits (Northern Ireland) Act 1992.
|
2.5
|
This Election will not apply to the extent that it relates to relevant employment income which is employment income of the earner by virtue of Chapter 3A of Part 7 of ITEPA (employment income: securities with artificially depressed market value).
|
2
|
The Election
|
3
|
Payment of the Employer's Liability
|
4.1
|
The Participant and the Company acknowledge that the Employer is under a duty to remit the Employer's Liability to HM Revenue and Customs on behalf of the Participant within 14 days after the end of the UK tax month during which the Taxable Event occurs, or such other period of time, as prescribed. The Participant agrees to pay to the Company and/or the Employer the Employer’s Liability on demand, at any time on or after the Taxable Event and hereby authorises the Company and/or the Employer to account for the Employer’s Liability to HM Revenue and Customs.
|
4.2
|
Without limitation to Clause 4.1 above, the Participant hereby authorises the Company and/or the Employer to collect the Employer's Liability from the Participant at any time after the Taxable Event:
|
a.
|
by deduction from salary or any other payment payable to the Participant at any time on or after the date of the Taxable Event; and/or
|
b.
|
directly from the Participant by payment in cash or cleared funds; and/or
|
c.
|
by arranging, on behalf of the Participant, for the sale of some of the securities which the Participant is entitled to receive in respect of the Awards; and/or
|
d.
|
through any other method as set forth in the relevant Award agreement entered into between the Participant and the Company.
|
4.3
|
The Company hereby reserves for itself and the Employer the right to withhold the transfer of any securities to the Participant until full payment of the Employer's Liability is collected from the Participant.
|
4
|
Duration of Election
|
5.1
|
The Participant and the Company agree to be bound by the terms of this Election regardless of whether the Participant is transferred abroad or is not employed by the Employer on the date on which the Employer's Liability becomes due. Any reference to the Company, the Employer and/or the Participant shall include that entity's successors in title and assigns as permitted in accordance with the terms of the Plan and Award agreement.
|
5.2
|
This Election will continue in effect until the earliest of the following:
|
a.
|
such time as both the Participant and the Company agree in writing that it should cease to have effect;
|
b.
|
on the date the Company serves written notice on the Participant terminating its effect;
|
c.
|
on the date HM Revenue and Customs withdraws approval of this Election; or
|
d.
|
on the date the Election ceases to have effect in accordance with its terms in respect of any outstanding Awards granted under the Plan.
|
By:
|
|
|
|
Title:
|
|
Registered Office:
|
100 Brook Drive
Green Park, Reading
RG2 6UJ
United Kingdom
|
Company Registration Number:
|
2642054
|
Corporation Tax District:
|
Oxon and Bucks Area
|
Corporation Tax Reference:
|
402 56090 10710
|
PAYE District:
|
East Hampshire and Wight Area
|
PAYE Reference:
|
581/S3033
|
2006 Employee Equity Incentive Plan
Notice of Grant of Stock Options and Option Agreement |
Synopsys, Inc.
ID: 56-1546236 690 East Middlefield Road Mountain View, CA 94043 |
%%FIRST_NAME%-% %%LAST_NAME%-%
%%ADDRESS_LINE_1%-%
%%ADDRESS_LINE_2%-%
%%CITY%-%, %%STATE%-% %%ZIPCODE%-%
%%COUNTRY%-%
|
Option Number: %%OPTION_NUMBER%-%
ID: %%EMPLOYEE_IDENTIFIER%-% |
Shares
|
Vest Type
|
Full Vest
|
Expiration
|
%%SHARES_PERIOD1%-%
|
On Vest Date
|
%%VEST_DATE_PERIOD1%-%
|
%%EXPIRE_DATE_PERIOD1%-%
|
%%SHARES_PERIOD2%-%
|
Quarterly
|
%%VEST_DATE_PERIOD2%-%
|
%%EXPIRE_DATE_PERIOD2%-%
|
PARTICIPANT:
|
Your address as on file with the Company at the time notice is given
|
* * * * *
Your signature below or online acceptance (where permitted) indicates that you have read this Agreement (including any appendices hereto) and agree to be bound by the terms and conditions of the Plan and this Agreement.
|
|
•
|
you agree that any Employer’s Liability that may arise in connection with or pursuant to the exercise or vesting of the Award, as applicable (and the acquisition of shares of the Company’s common stock) or other taxable events in connection with the Award will be transferred to you; and
|
•
|
you authorise the Company and/or your employer to recover an amount sufficient to cover this liability by any method set forth in the relevant Award Agreement and/or the Joint Election.
|
1.
|
Parties
|
(A)
|
You, the individual who has obtained access to this Election (the “Participant”), who is employed by one of the employing companies listed in the attached schedule (the “Employer”) and who is eligible to receive stock options (“Options”) and/or restricted stock units (“RSUs”) (each an “Award” and together, the “Awards”) pursuant to the terms and conditions of the Synopsys, Inc. 2006 Employee Equity Incentive Plan (the “Plan”), and
|
(B)
|
Synopsys, Inc. of 690 East Middlefield Road, Mountain View, California 94043, United States (the “Company”), which may grant Awards under the Plan and is entering this Election on behalf of the Employer.
|
2.
|
Purpose of Election
|
2.1.
|
This Election relates to the Employer's secondary Class 1 National Insurance Contributions (the “Employer's Liability”) which may arise on the occurrence of a “Taxable Event” which gives rise to relevant employment income within section 4(4)(a) and/or paragraph 3B(1A) of Schedule 1 of the Social Security Contributions and Benefits Act 1992 (“SSCBA”), including but not limited to:
|
a.
|
the acquisition of securities pursuant to the Awards (pursuant to section 477(3)(a) ITEPA); and/or
|
b.
|
the assignment or release of the Awards in return for consideration (pursuant to section 477(3)(b) ITEPA); and/or
|
c.
|
the receipt of any other benefit in connection with the Awards other than a benefit within (i) or (ii) above (pursuant to section 477(3)(c) ITEPA); and/or
|
d.
|
post-acquisition events relating to the Awards or the securities acquired pursuant to the Awards (within section 426 ITEPA); and/or
|
e.
|
post-acquisition events relating to the Awards or the securities acquired pursuant to the Awards (within section 438 ITEPA).
|
2.2.
|
This Election is made in accordance with paragraph 3B(1) of Schedule 1 to SSCBA.
|
2.3.
|
This Election applies to all Awards granted to the Participant under the Plan on or after May 22, 2009 up to the termination date of the Plan.
|
2.4.
|
This Election does not apply in relation to any liability, or any part of any liability, arising as a result of regulations being given retrospective effect by virtue of section 4B(2) of either the SSCBA, or the Social Security Contributions and Benefits (Northern Ireland) Act 1992.
|
2.5.
|
This Election will not apply to the extent that it relates to relevant employment income which is employment income of the earner by virtue of Chapter 3A of Part 7 of ITEPA (employment income: securities with artificially depressed market value).
|
3.
|
The Election
|
4.
|
Payment of the Employer's Liability
|
4.1.
|
The Participant and the Company acknowledge that the Employer is under a duty to remit the Employer's Liability to HM Revenue and Customs on behalf of the Participant within 14 days after the end of the UK tax month during which the Taxable Event occurs, or such other period of time, as prescribed. The Participant agrees to pay to the Company and/or the Employer the Employer’s Liability on demand, at any time on or after the Taxable Event and hereby authorises the Company and/or the Employer to account for the Employer’s Liability to HM Revenue and Customs.
|
4.2.
|
Without limitation to Clause 4.1 above, the Participant hereby authorises the Company and/or the Employer to collect the Employer's Liability from the Participant at any time after the Taxable Event:
|
a.
|
by deduction from salary or any other payment payable to the Participant at any time on or after the date of the Taxable Event; and/or
|
b.
|
directly from the Participant by payment in cash or cleared funds; and/or
|
c.
|
by arranging, on behalf of the Participant, for the sale of some of the securities which the Participant is entitled to receive in respect of the Awards; and/or
|
d.
|
through any other method as set forth in the relevant Award agreement entered into between the Participant and the Company.
|
4.3.
|
The Company hereby reserves for itself and the Employer the right to withhold the transfer of any securities to the Participant until full payment of the Employer's Liability is collected from the Participant.
|
5.
|
Duration of Election
|
5.1.
|
The Participant and the Company agree to be bound by the terms of this Election regardless of whether the Participant is transferred abroad or is not employed by the Employer on the date on which the Employer's Liability becomes due. Any reference to the Company, the Employer and/or the Participant shall include that entity's successors in title and assigns as permitted in accordance with the terms of the Plan and Award agreement.
|
5.2.
|
This Election will continue in effect until the earliest of the following:
|
a.
|
such time as both the Participant and the Company agree in writing that it should cease to have effect;
|
b.
|
on the date the Company serves written notice on the Participant terminating its effect;
|
c.
|
on the date HM Revenue and Customs withdraws approval of this Election; or
|
d.
|
on the date the Election ceases to have effect in accordance with its terms in respect of any outstanding Awards granted under the Plan.
|
|
Synopsys, Inc.
|
Name:
Title:
|
Registered Office:
|
100 Brook Drive
Green Park, Reading
RG2 6UJ
United Kingdom
|
Company Registration Number:
|
2642054
|
Corporation Tax District:
|
Oxon and Bucks Area
|
Corporation Tax Reference:
|
402 56090 10710
|
PAYE District:
|
East Hampshire and Wight Area
|
PAYE Reference:
|
581/S3033
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Synopsys, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 17, 2017
|
|
/s/ Aart J. de Geus
|
|
|
Aart J. de Geus
Co-Chief Executive Officer and Chairman
(Co-Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Synopsys, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 17, 2017
|
|
/s/ Chi-Foon Chan
|
|
|
Chi-Foon Chan
Co-Chief Executive Officer and President
(Co-Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Synopsys, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 17, 2017
|
|
/s/ Trac Pham
|
|
|
Trac Pham
Chief Financial Officer
(Principal Financial Officer)
|
/s/ Aart J. de Geus
|
|
Aart J. de Geus
Co-Chief Executive Officer and Chairman
|
|
|
|
/s/ Chi-Foon Chan
|
|
Chi-Foon Chan
Co-Chief Executive Officer and President
|
|
|
|
/s/ Trac Pham
|
|
Trac Pham
Chief Financial Officer
|
|